恶性胸膜间皮瘤23例临床分析
摘要
<正>恶性胸膜间皮瘤(MPM)源于胸膜间皮细胞,是胸膜原发性肿瘤,发病率极低,国内报道该病的发病率为0. 3/1 0万~0.5/1 0万[1],临床表现及早期影像学缺乏特异性,早期发现困难,误诊率高。本文通过对我院2007年1月至2016年12月期间的恶性胸膜间皮瘤确诊患者临床资料进行回顾性分析,以提高对该病的认识。1临床资料1. 1一般资料本组共2 3例,其中男8例,女1 5例;年
引文
[1]王玉艳,张弘,白桦,等.恶性胸膜间皮瘤临床特征及分子标志物与预后的关系[J].中华结核和呼吸杂志,2013,36(3):162.
[2] Richards WG,Godleski JJ,Yeap BY, et al. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases[J]. Cancer, 2010,116(6):1150.
[3]谢红波,杨有优,王思云.CT和PET/CT在恶性胸膜间皮瘤诊断中的应用[J].中山大学学报(医学科学版),2009, 30(z1):97.
[4]陆国秀,张彩霞,徐薇娜,等. 18F-FDG PET-CT对恶性胸膜间皮瘤诊断及预后评估的价值[J].同位素,2012, 25(1):58.
[5]李莉,杜钟珍,孙昕,等.可弯曲式内科胸腔镜在恶性胸膜间皮瘤中的诊断价值[J].临床肺科杂志,2010,15(7):991.
[6]刘先军,彭吉霞,涂明利,等.电子胸腔镜下恶性胸膜间皮瘤的表现及其诊断价值[J].临床内科杂志,2009, 26(5):343.
[7] Henderson DW,Reid G, Kao SC,et al. Challenges and controversies in the diagnosis of mesothelioma:Part1. Cytologyonly diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia,and biomarkers[J]. J Clin Pathol, 2013, 66(10):847.
[2] Richards WG,Godleski JJ,Yeap BY, et al. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases[J]. Cancer, 2010,116(6):1150.
[3]谢红波,杨有优,王思云.CT和PET/CT在恶性胸膜间皮瘤诊断中的应用[J].中山大学学报(医学科学版),2009, 30(z1):97.
[4]陆国秀,张彩霞,徐薇娜,等. 18F-FDG PET-CT对恶性胸膜间皮瘤诊断及预后评估的价值[J].同位素,2012, 25(1):58.
[5]李莉,杜钟珍,孙昕,等.可弯曲式内科胸腔镜在恶性胸膜间皮瘤中的诊断价值[J].临床肺科杂志,2010,15(7):991.
[6]刘先军,彭吉霞,涂明利,等.电子胸腔镜下恶性胸膜间皮瘤的表现及其诊断价值[J].临床内科杂志,2009, 26(5):343.
[7] Henderson DW,Reid G, Kao SC,et al. Challenges and controversies in the diagnosis of mesothelioma:Part1. Cytologyonly diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia,and biomarkers[J]. J Clin Pathol, 2013, 66(10):847.